Display options
Share it on

ESC Heart Fail. 2022 Jan 10; doi: 10.1002/ehf2.13780. Epub 2022 Jan 10.

First-in-human experience of preload regulation with percutaneous transluminal caval flow regulation in heart failure with reduced ejection fraction patients.

ESC heart failure

José E Herrera, José A Herrera, Bartolomé Finizola, Eleazar García, Luis E Velasco, William R Torres, Gabriel D'empaire, José A Octavio, Juan A Marqués, Robert A Levine, Igor F Palacios

Affiliations

  1. Asociación Cardiológica de Occidente, ASCARDIO, Universidad Central 'Lisandro Alvarado' (UCLA), Barquisimeto, Venezuela.
  2. Hospital de Clínicas Caracas, Caracas, Venezuela.
  3. Cardiología Experimental Universidad Central, Caracas, Venezuela.
  4. Massachusetts General Hospital, Boston, MA, USA.

PMID: 35014208 DOI: 10.1002/ehf2.13780

Abstract

AIMS: This study aims to investigate the acute haemodynamic effects of percutaneous transluminal flow regulation (PTCR®) with an inferior vena cava regulator balloon in heart failure patients. Preload reduction in heart failure has been achieved with high potency diuretics. However, no study has been conducted in humans to assess the effect of inferior vena cava intermittent occlusion for preload reduction.

METHODS AND RESULTS: Six patients were included in the study: four men (55 ± 6 years old) and two women (63 ± 4 years old). Baseline evaluations included Doppler echocardiogram, coronary angiogram, and right heart catheterization. Caval balloon was kept inflated for 30 min, and right catheterization and control echocardiogram were performed while the balloon was still inflated. The balloon was then deflated and removed. Right haemodynamic variables were evaluated before balloon insertion and with the inflated balloon. The mean right atrial pressure decreased by 42.59% (P = 0.005); systolic right ventricular pressure decreased by 30.19% (P < 0.003); mean pulmonary arterial pressure decreased by 25.33% (P < 0.043); mean pulmonary capillary wedge pressure decreased by 31.37% (P > 0.016); and cardiac output increased by 9.92% (P < 0.175).

CONCLUSIONS: The haemodynamic and echocardiographic changes obtained in our study using PTCR® suggest that this innovative approach can play a beneficial role in the heart failure treatment.

© 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

Keywords: Caval flow regulation natural phenomenon; Dynamic regulation; Dynamic stenosis; Heart failure; Inferior vena cava; Percutaneous transluminal caval flow regulation PTCR®

References

  1. Androne AS, Hryniewicz K, Hudaihed A, Mancini D, Lamanca J, Katz SD. Relation of unrecognized hypervolemia in chronic heart failure to clinical status, hemodynamics, and patient outcomes. Am J Cardiol 2004; 93: 1254-1259. - PubMed
  2. Wayne LM. Fluid volume overload and congestion in heart failure: time to reconsider pathophysiology and how volume is assessed. Circ Heart Fail 2016; 9: e002922. - PubMed
  3. Constanzo MR, Guglin ME, Saltzberg MT, Jessup ML, Bart BA, Teerlink JR, Jaski BE, Fang JC, Feller ED, Haas GJ, Anderson AS. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 2007; 49: 675-683. - PubMed
  4. Herrera JE, Herrera JA, Marques JE, Mendoza I. A novel method to reduce preload mechanically in patients with congestive heart failure, the dynamic restriction of flow in the inferior vena cava. Eur J Heart Fail Supplements 2011; 10: 4. https://onlinelibrary.wiley.com/doi/epdf/10.1093/eurjhf/hsr005 - PubMed
  5. Herrera JE, Herrera JA, Palacios IF. TCT-428 first percutaneous transluminal caval flow restriction in one patent with heart failure. J Am Coll Cardiol 2014; 64: B125-B126. - PubMed
  6. Herrera JE, Cubeddu R, Torres W, Velasco L, Finizola B, D'Empaire G, Octavio JA, Garcia E, Herrera JA, Levine R, Palacios IF. TCT-733 acute hemodynamic effects percutaneous transluminal caval flow intermittent restriction with balloon in ischemic and non-ischemic heart failure patients. J Am Coll Cardiol 2015; 66: B299. - PubMed
  7. Bastos MB, Burkhoff D, Maly J, Daemen J, den Uil CA, Ameloot K, Lenzen M, Mahfoud F, Zijlstra F, Schreuder JJ, van Mieghem NM. Invasive left ventricle pressure-volume analysis: overview and practical clinical implications. Eur Heart J 2020; 41: 1286-1297. - PubMed
  8. Pelà G, Regolisti G, Coghi P, Cabassi A, Basile A, Cavatorta A, Manca C, Borghetti A. Effects of the reduction of preload on left and right ventricular myocardial velocities analyzed by Doppler tissue echocardiography in healthy subjects. Eur J Echocardiogr 2004; 5: 262-271. - PubMed
  9. Popović ZB, Desai MY, Buakhamsri A, Puntawagkoon C, Borowski A, Levine BD, Tang WWH, Thomas JD. Predictors of mitral annulus early diastolic velocity: impact of long-axis function, ventricular filling pattern, and relaxation. Eur J Echocardiogr 2011; 12: 818-825. - PubMed
  10. Bamber JH, Nolas V. The influence of vena cava occlusion on predictive haemodynamic parameters. Anaesthesia 2015; 70: 1209-1210. - PubMed
  11. Gupta R, Testani J, Collins S. Diuretic resistance in heart failure. Curr Heart Fail Rep 2019; 16: 57-66. - PubMed

Publication Types

Grant support